Rhevera Medical

The right patients for the #DETOURSystem are already in your practice. Explore the positive clinical outcomes for percutaneous transmural arterial bypass (#PTAB) with the DETOUR System in patients with long, complex SFA disease, including 4 patient types underserved by traditional treatment options. 🌎 https://lnkd.in/gV8EnE_3 Safety Info: https://lnkd.in/gsfj52-H Rhevera Medical Holdings is the parent company of Endologix LLC. Endologix LLC is the legal manufacturer of the company's devices. #medtech #healthinnovation #PeripheralArteryDisease

📣 Major announcement: Endologix is now Rhevera Medical. A new identity for a company built around one purpose: preserving and restoring the blood flow that sustains life. Since its founding in 1992, Endologix has built its business in aortic repair and has since expanded across the vascular space. Rhevera Medical now reflects the full portfolio and where we are headed as a company. Welcome to what's next. 🔗 Read the official press release: https://lnkd.in/gPQJZnxF Rhevera Medical Holdings is the parent company of Endologix LLC. Endologix LLC is the legal manufacturer of the company's devices. #RheveraMedical #MedTech #VascularHealth #HealthInnovation

When faced with a calcified #abdominalaorticaneurysm neck, what's your move? Protect the neck with an exceptional #EVAR therapy. The exceptional #ALTO abdominal stent graft with an exclusive adaptive sealing technology creates an effective seal around the vessel wall, conforming to the patient’s native anatomy. Learn more about ALTO, where versatility and durability meet with proven outcomes over 10 years. https://lnkd.in/gMdHsAJQ The 10-year clinical outcomes discussed reflect data from the Ovation platform and Adaptive Sealing Technology (AST) experience. ALTO incorporates the same foundational AST but was introduced more recently and therefore does not have 10 years of device-specific follow-up. Long-term outcome data include patients treated with earlier-generation Ovation devices utilizing AST. ISI: https://lnkd.in/gvXdfxd3 #vascularsurgery #medtech #healthcareinnovation #vascularinnovation #medicalinnovation

When faced with a calcified #abdominalaorticaneurysm neck, what's your move? Protect the neck with the #ALTO abdominal stent graft. ALTO, with an exclusive adaptive sealing technology, provides a custom seal and conforms to the needs of specialized anatomies. Learn more about ALTO, where versatility and durability meet with proven outcomes over 10 years. https://lnkd.in/gMdHsAJQ The 10-year clinical outcomes discussed reflect data from the Ovation platform and Adaptive Sealing Technology (AST) experience. ALTO incorporates the same foundational AST but was introduced more recently and therefore does not have 10 years of device-specific follow-up. Long-term outcome data include patients treated with earlier-generation Ovation devices utilizing AST. ISI: https://lnkd.in/gvXdfxd3 #vascularsurgery #medtech #healthcareinnovation #vascularinnovation #medicalinnovation

When faced with a reverse taper #abdominalaorticaneurysm, what's your move? Protect the neck. Because long-term success begins at the neck. #ALTO's exclusive Adaptive Sealing Technology conforms to the patients native anatomy, creating an effective circumferential seal regardless of the aortic neck. Adaptive Sealing Technology demonstrates exceptional outcomes up to 10 years. Learn more about ALTO, where versatility and durability meet: https://lnkd.in/gMdHsAJQ The 10-year clinical outcomes discussed reflect data from the Ovation platform and Adaptive Sealing Technology (AST) experience. ALTO incorporates the same foundational AST but was introduced more recently and therefore does not have 10 years of device-specific follow-up. Long-term outcome data include patients treated with earlier-generation Ovation devices utilizing AST. ISI: https://lnkd.in/gvXdfxd3 #vascularsurgery #medtech #healthcareinnovation #vascularinnovation #medicalinnovation #EVAR

Long-term success begins at the neck. Do you recall this short neck, treated using the #ALTO abdominal stent graft with Adaptive Sealing Technology? Keep watching for the results at 3-years. Learn more about ALTO, where versatility and durability meet with proven outcomes over 10 years. https://lnkd.in/gMdHsAJQ The 10-year clinical outcomes discussed reflect data from the Ovation platform and Adaptive Sealing Technology (AST) experience. ALTO incorporates the same foundational AST but was introduced more recently and therefore does not have 10 years of device-specific follow-up. Long-term outcome data include patients treated with earlier-generation Ovation devices utilizing AST. ISI: https://lnkd.in/gvXdfxd3 #EVAR #vascularsurgery #medTwitter #medtech #healthcareinnovation #vascularinnovation